Navigation Links
Covidien supports NOSCAR US multicenter human trial
Date:7/8/2011

OAK BROOK, Ill., July 8, 2011 The Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), is pleased to announce a grant from Covidien to support the U.S. multicenter human trial on transoral and transvaginal cholecystectomies (gallbladder removal) using Natural Orifice Translumenal Endoscopic Surgery (NOTES).

"NOSCAR is grateful to Covidien for supporting the NOTES human trial research and helping to advance this minimally invasive technique," said Steven D. Schwaitzberg, MD, NOSCAR Research Subcommittee Co-Chair.

Cholecystectomy, or gallbladder removal, is one of the most common surgeries in the U.S.; approximately 750,000 are performed annually. The NOSCAR study uses the mouth or vagina as routes to the gallbladder. Rather than making up to five incisions in the abdominal wall, tools are passed down the mouth and through a hole created in the stomach (transoral/transgastric) or through the vagina (transvaginal).

The prospective multicenter trial compares NOTES cholecystectomy versus conventional laparoscopic cholecystectomy. NOSCAR has granted funds to selected institutions to conduct these trials. Institutions participating in the trial have demonstrated a strong commitment to developing the basic science that forms the foundation of NOTES and have already performed human NOTES cases under an Institutional Review Board protocol; approximately 200 patients will be enrolled in the clinical trial.

"Covidien is dedicated to collaborating with the surgical community to drive the adoption of advanced minimally and non-invasive surgical techniques through well-designed, robust clinical studies," said Michael Tarnoff, M.D., Chief Medical Officer, Covidien. "NOTES may represent the next wave in minimally invasive surgery with significant potential to improve patient outcomes and reduce hospital stays. Covidien is pleased that its funding will support NOSCAR's efforts to ensure the most safe and effective development of NOTES procedures and techniques throughout the world."

"The human trials have already achieved very positive results and we now have a total of five institutions and 35 patients participating in the trial," said Michael L. Kochman, MD, NOSCAR Research Subcommittee Co-Chair.


'/>"/>

Contact: Anne Brownsey
abrownsey@asge.org
630-570-5635
American Society for Gastrointestinal Endoscopy
Source:Eurekalert

Related medicine news :

1. Nature Publishing Group supports ASCB Childcare Awards for scientist-parents at annual meeting
2. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
3. Horizon Pharma supports fellows and students with AGA Abstract Prizes
4. Strong evidence supports prognostic value of circulating tumor cells in breast cancer
5. International Diabetes Federation supports surgery to treat diabetes
6. Autism Speaks supports new diagnostic code for individuals with autism with history of wandering
7. $1.9 million NIH grant supports research in the most common soft tissue tumor in children
8. GSA supports new US call for improved nutrition and physical activity
9. US Department of Defense supports study of brain, eye injuries in military personnel
10. Scientific evidence supports effectiveness of Chinese drug for cataracts
11. British Study Supports Mammograms for Some Women Under 50
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
Breaking Medicine Technology: